Vegetables have long been known to be healthy and filled with vitamins, but studies are now shining a fresh light on one vegetable in particular — celery.
This stalky vegetable contains apigenin, which studies show is a substance known to impact breast cancer cell growth.
“Apigenin inhibits progression and development of these tumors by inducing apoptosis, inhibiting cell proliferation, and reducing expression of [the tumor]. Moreover, apigenin reduced levels of vascular endothelial growth factor (VEGF) without altering blood vessel density,” according to a published study conducted by the University of Missouri Department of Pathobiology.
The substance found in celery was first tested as part of a treatment used in postmenopausal women to decrease the risk of endometrial cancer due to taking progestin/estrogen in their recovery.
The University of Missouri released a statement about the findings of their research, saying:
“Apigenin slowed the progression of human breast cancer cells in three ways: by inducing cell death, by inhibiting cell proliferation, and by reducing expression of a gene associated with cancer growth. Blood vessels responsible for feeding cancer cells also had smaller diameters in apigenin-treated mice compared to untreated mice. Smaller vessels mean restricted nutrient flow to the tumors and may have served to starve the cancer as well as limiting its ability to spread.”
A group of mice were test subjects which were exposed to apigenin after it was concluded that they had a specific type of breast cancer. Another group was giving a placebo.
The mice that received the apigenin treatment showed significant differences in comparison to those not receiving the treatment. The mice treated with it had fewer tumors and the cancer cells grew slower.
“Six to 10 million women in the United States receive hormone replacement therapy (HRT). We know that certain synthetic hormones used in HRT accelerate breast tumor development,” another statement made by the University of Missouri researchers said.